Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Equillium, Inc. | 20,000 | reported | 21 May 2025 | tx 2+60,000 |
| Checkmate Pharmaceuticals, Inc. | 0 | reported | 31 May 2022 | tx 4+30,030−30,030 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 21 May 2025 | GRANT_AWARD | Equillium, Inc. | 20,000 | 0.00 USD | deriv |
| 11 Dec 2024 | GRANT_AWARD | Equillium, Inc. | 40,000 | 0.00 USD | deriv |
| 31 May 2022 | OTHER | Checkmate Pharmaceuticals, Inc. | 20,000 | — | deriv |
| 31 May 2022 | OTHER | Checkmate Pharmaceuticals, Inc. | 10,030 | — | deriv |
| 16 Jun 2021 | GRANT_AWARD | Checkmate Pharmaceuticals, Inc. | 10,030 | 0.00 USD | deriv |
| 10 Nov 2020 | GRANT_AWARD | Checkmate Pharmaceuticals, Inc. | 20,000 | 0.00 USD | deriv |